REGENXBIO Inc.RGNXNASDAQ
LOADING
|||
Gross Profit Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
-362.09%
↓ 319% below average
Average (39q)
165.03%
Historical baseline
Range
High:2153.40%
Low:-1899.08%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -362.09% |
| Q2 2025 | -85.69% |
| Q1 2025 | 474.49% |
| Q4 2024 | 26.13% |
| Q3 2024 | 54.08% |
| Q2 2024 | 7.07% |
| Q1 2024 | 7.82% |
| Q4 2023 | -59.82% |
| Q3 2023 | 57.36% |
| Q2 2023 | -30.11% |
| Q1 2023 | -19.05% |
| Q4 2022 | 38.34% |
| Q3 2022 | -31.88% |
| Q2 2022 | 203.00% |
| Q1 2022 | -98.27% |
| Q4 2021 | 2153.40% |
| Q3 2021 | 36.44% |
| Q2 2021 | -12.95% |
| Q1 2021 | 25.43% |
| Q4 2020 | -86.28% |
| Q3 2020 | 586.32% |
| Q2 2020 | -16.53% |
| Q1 2020 | 78.45% |
| Q4 2019 | -34.65% |
| Q3 2019 | 105.01% |
| Q2 2019 | 596.37% |
| Q1 2019 | -97.75% |
| Q4 2018 | 692.11% |
| Q3 2018 | -86.76% |
| Q2 2018 | -72.18% |
| Q1 2018 | 1206.43% |
| Q4 2017 | -1899.08% |
| Q3 2017 | -87.55% |
| Q2 2017 | 1340.93% |
| Q1 2017 | -73.35% |
| Q4 2016 | 1417.78% |
| Q3 2016 | -95.21% |
| Q2 2016 | 531.99% |
| Q1 2016 | -91.65% |
| Q4 2015 | 302.94% |